Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.49 | 9e-14 |
mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.38 | 6e-10 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-08 |
mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.27 | 4e-08 |
mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.34 | 7e-08 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-08 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.36 | 1e-07 |
mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-07 |
mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.33 | 5e-07 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-06 |